Every SEC Form 3/4/5 on record for this filer (CIK 1219023) — 7 issuers, 28 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Director | 2017-10-04 → 2026-06-25 | 13 | −$4M |
| INSM | INSMED Inc | Director | 2016-05-23 → 2026-02-11 | 12 | −$451,535 |
| XFOR | X4 Pharmaceuticals, Inc | Director | 2019-06-19 → 2025-06-10 | 7 | — |
| MNLO | Menlo Therapeutics Inc. | Director · lapsed | 2018-01-24 → 2019-08-08 | 3 | — |
| ASNS | ACTELIS NETWORKS INC | Director · lapsed | 2017-11-15 → 2018-06-07 | 4 | — |
| ROKA | Roka BioScience, Inc. | Director · lapsed | 2016-06-24 → 2017-06-30 | 2 | — |
| RLYP | Relypsa Inc | Director · lapsed | 2016-06-08 → 2016-09-02 | 3 | −$19,591 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| INSM | 2025-06-04 | Sell | 3,000 | $73.27 | $219,810 | 97,723 |
| INSM | 2025-06-03 | Sell | 3,250 | $71.30 | $231,725 | 100,723 |
| RYTM | 2025-06-03 | Sell | 55,558 | $65.15 | $4M | 12,873 |
| RYTM | 2025-06-03 | Sell | 9,873 | $65.64 | $648,064 | 3,000 |
4 of 7 issuers are covered and open a security page; the rest are on file here only.
